- Home
- CADL vs MG Comparison
CADL vs MG Comparison
Compare CADL & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- MG
- Stock Information
- Founded
- CADL 1999
- MG 1978
- Country
- CADL United States
- MG United States
- Employees
- CADL 38
- MG N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- MG Military/Government/Technical
- Sector
- CADL Health Care
- MG Consumer Discretionary
- Exchange
- CADL Nasdaq
- MG Nasdaq
- Market Cap
- CADL 252.0M
- MG 236.5M
- IPO Year
- CADL 2021
- MG 2009
- Fundamental
- Price
- CADL $5.10
- MG $8.15
- Analyst Decision
- CADL Strong Buy
- MG
- Analyst Count
- CADL 5
- MG 0
- Target Price
- CADL $21.40
- MG N/A
- AVG Volume (30 Days)
- CADL 923.7K
- MG 172.0K
- Earning Date
- CADL 08-12-2025
- MG 07-30-2025
- Dividend Yield
- CADL N/A
- MG N/A
- EPS Growth
- CADL N/A
- MG N/A
- EPS
- CADL N/A
- MG 0.47
- Revenue
- CADL N/A
- MG $706,813,000.00
- Revenue This Year
- CADL N/A
- MG $0.81
- Revenue Next Year
- CADL N/A
- MG $2.93
- P/E Ratio
- CADL N/A
- MG $17.24
- Revenue Growth
- CADL N/A
- MG N/A
- 52 Week Low
- CADL $3.79
- MG $7.06
- 52 Week High
- CADL $14.60
- MG $12.44
- Technical
- Relative Strength Index (RSI)
- CADL 44.91
- MG 54.76
- Support Level
- CADL $4.73
- MG $7.47
- Resistance Level
- CADL $5.07
- MG $8.13
- Average True Range (ATR)
- CADL 0.28
- MG 0.19
- MACD
- CADL -0.01
- MG 0.07
- Stochastic Oscillator
- CADL 48.38
- MG 85.33
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.